Hide metadata

dc.date.accessioned2019-01-21T14:34:46Z
dc.date.available2019-01-21T14:34:46Z
dc.date.created2018-11-09T12:12:33Z
dc.date.issued2018
dc.identifier.citationHeier, Martin Ofstad, Anne Pernille Borja, Mark S. Brunborg, Cathrine Endresen, Knut Gullestad, Lars Birkeland, Kåre I. Johansen, Odd Erik Oda, Michael N. . High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes. Atherosclerosis. 2018, 1-5
dc.identifier.urihttp://hdl.handle.net/10852/66212
dc.description.abstractBackground and aims: Measures of HDL function are emerging tools for assessing cardiovascular disease (CVD) event risk. HDL-apoA-I exchange (HAE) reflects HDL capacity for reverse cholesterol transport. Methods: HAE was measured in 93 participants with type 2 diabetes (T2D) and at least one additional CVD risk factor in the Asker and Bærum Cardiovascular Diabetes study. At baseline and after seven years, the atherosclerotic burden was assessed by invasive coronary angiography. Major CVD events were registered throughout the study. Results: Linear regression analysis demonstrated a significant inverse association between HAE and atherosclerotic burden. Cox proportional hazard regression analysis showed a significant association between HAE and a composite of major CVD events when controlling for waist-hip ratio, HR = 0.89, 95% CI = 0.80–1.00 and p=0.040. Conclusions: Despite the relatively small size of the study population and the limited number of CVD events, these findings suggest that HAE provides valuable information in determining CVD risk.en_US
dc.languageEN
dc.publisherElsevier Science
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleHigh-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetesen_US
dc.typeJournal articleen_US
dc.creator.authorHeier, Martin
dc.creator.authorOfstad, Anne Pernille
dc.creator.authorBorja, Mark S.
dc.creator.authorBrunborg, Cathrine
dc.creator.authorEndresen, Knut
dc.creator.authorGullestad, Lars
dc.creator.authorBirkeland, Kåre I.
dc.creator.authorJohansen, Odd Erik
dc.creator.authorOda, Michael N.
cristin.unitcode185,53,46,10
cristin.unitnamePediatri
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1628667
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Atherosclerosis&rft.volume=&rft.spage=1&rft.date=2018
dc.identifier.jtitleAtherosclerosis
dc.identifier.startpage1
dc.identifier.endpage5
dc.identifier.doihttp://dx.doi.org/10.1016/j.atherosclerosis.2018.07.005
dc.identifier.urnURN:NBN:no-69428
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0021-9150
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/66212/2/1-s2.0-S0021915018312012-main.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International